Laboratory of Neurobiology, Institute of Neurosciences, IdISSC, Hospital Clínico San Carlos, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Preclinical Evaluation Unit, Medical and Pharmaceutical Biotechnology Unit, CIATEJ-CONACyT, Guadalajara 44270, Mexico.
Int J Mol Sci. 2022 Oct 18;23(20):12473. doi: 10.3390/ijms232012473.
Over the past thirty years, research has shown the huge potential of chitosan in biomedical applications such as drug delivery, tissue engineering and regeneration, cancer therapy, and antimicrobial treatments, among others. One of the major advantages of this interesting polysaccharide is its modifiability, which facilitates its use in tailor-made applications. In this way, the molecular structure of chitosan has been conjugated with multiple molecules to modify its mechanical, biological, or chemical properties. Here, we review the conjugation of chitosan with some bioactive molecules: hydroxycinnamic acids (HCAs); since these derivatives have been probed to enhance some of the biological effects of chitosan and to fine-tune its characteristics for its application in the biomedical field. First, the main characteristics of chitosan and HCAs are presented; then, the currently employed conjugation strategies between chitosan and HCAs are described; and, finally, the studied biomedical applications of these derivatives are discussed to present their limitations and advantages, which could lead to proximal therapeutic uses.
在过去的三十年中,研究表明壳聚糖在药物输送、组织工程和再生、癌症治疗和抗菌处理等生物医学应用中具有巨大的潜力。这种有趣的多糖的主要优点之一是其可修饰性,这使其易于用于定制应用。通过这种方式,壳聚糖的分子结构已经与多种分子结合,以改变其机械、生物或化学性质。在这里,我们回顾了壳聚糖与一些生物活性分子的共轭:对羟基肉桂酸(HCAs);因为这些衍生物已经被探测到可以增强壳聚糖的一些生物学效应,并调整其特性,使其在生物医学领域得到应用。首先,介绍了壳聚糖和 HCAs 的主要特性;然后,描述了壳聚糖和 HCAs 之间目前采用的共轭策略;最后,讨论了这些衍生物的研究生物医学应用,以展示它们的局限性和优点,这可能导致接近治疗用途。